Format

Send to

Choose Destination
See comment in PubMed Commons below
Future Oncol. 2009 Sep;5(7):953-8. doi: 10.2217/fon.09.70.

PET/CT imaging to guide cervical cancer therapy.

Author information

1
Mallinckrodt Institute of Radiology, Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA. pgrigsby@wustl.edu

Abstract

Fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography has been utilized for many oncologic indications. It has been found to be especially useful in the management of patients with carcinoma of the uterine cervix. PET imaging defines the extent of the disease at diagnosis. It aids in selecting therapy, such as surgery, radiation therapy, chemotherapy or combinations thereof. For radiotherapy, the metabolically active disease can be specifically targeted with radiotherapy planning. Once therapy is complete, FDG-PET is utilized to evaluate the metabolic response to therapy. The 3-month post-therapy PET scan has been demonstrated to be highly predictive of long-term survival outcome. Surveillance after completion of therapy and evaluation of clinically suspected recurrent disease are also uses of FDG-PET in patients with cervical cancer.

PMID:
19792965
DOI:
10.2217/fon.09.70
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center